Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology

Active, not recruiting

• Conditions: Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm
• Interventions: Behavioral: Survey Administration

• Registration Number: NCT05496972
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.

Detailed Description

Primary Objective:

To characterize patient and provider satisfaction with telemedicine in RO

Secondary Objective:

* To provide evidence for or against the use of telemedicine in radiation oncology (RO)

* To assess the feasibility of and value added by telemedicine in RO

* To describe barriers and facilitators to telemedicine in RO

* To identify preferred use cases for telemedicine in RO

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2021-04-21
• Study First Submitted: 2022-08-08
• Study First Submitted QC: 2022-08-09
• Study First Posted: 2022-08-11
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-13
• Last Update Posted: 2024-12-17
• Primary Completion: 2027-07-01
• Study Completion: 2027-07-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients will be eligible if they are aged 18 or older and have undergone at least 1 telemedicine encounter (video visit) with the radiation oncology department at MD Anderson or its affiliates within 2 months from the initiation of the study (and prospectively as the study enrolls). This would include weekly see visits, follow-up visits, or consultations
• English speaking
• Access to email and internet to complete the survey
• Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience

Read More

Exclusion Criteria

• Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Telemedicine Visits	Survey Administration	Participants are asked to fill out a survey about their experience.

Primary Outcome Measures

Name	Time	Method
Patient satisfaction survey with telemedicine in radiation oncology (RO)	through study completion and average of one year.	Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.
Provider satisfaction survey with telemedicine in radiation oncology (RO)	through study completion and average of one year.	Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.

Trial Locations

Locations (1)

MD Anderson Cancer Center; 🇺🇸 Houston, Texas, United States